BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19380809)

  • 1. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
    Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
    Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus.
    Huck S; Jamin C; Youinou P; Zouali M
    J Autoimmun; 1998 Oct; 11(5):449-55. PubMed ID: 9802928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients.
    Mi XB; Zeng FQ
    Acta Pharmacol Sin; 2008 Jan; 29(1):105-12. PubMed ID: 18158872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
    Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
    Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells.
    Li Y; Zhao M; Yin H; Gao F; Wu X; Luo Y; Zhao S; Zhang X; Su Y; Hu N; Long H; Richardson B; Lu Q
    Arthritis Rheum; 2010 May; 62(5):1438-47. PubMed ID: 20131288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus.
    Díaz-Alderete A; Crispin JC; Vargas-Rojas MI; Alcocer-Varela J
    J Autoimmun; 2004 Dec; 23(4):379-83. PubMed ID: 15571932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
    Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
    Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
    J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
    Lei W; Luo Y; Lei W; Luo Y; Yan K; Zhao S; Li Y; Qiu X; Zhou Y; Long H; Zhao M; Liang Y; Su Y; Lu Q
    Scand J Rheumatol; 2009; 38(5):369-74. PubMed ID: 19444718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
    Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
    Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
    J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
    Kanda N; Watanabe S
    J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
    Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
    Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.